FDA Authorizes Emergency Use Of Devices In War Time, Bill Signed By The President Clarifies
President Trump signed off on legislation allowing US FDA to authorize additional emergency uses for medical products to reduce deaths and impacts of injuries caused by "agents of war." The signature ends a turf battle between FDA and the Department of Defense over authorizing products needed quickly under the emergency conditions of war.
You may also be interested in...
FDA and the US Department of Defense launched a program to prioritize development of medical products for use in the battlefield. The program implements recently enacted compromise legislation that resolved a turf battle between the two agencies.
All 'top priority' battlefield products will get FDA review by June 30; longer term plan includes draft guidance on development of products designed for use in austere conditions.
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.